Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
BeOne Medicines
Memorial Sloan Kettering Cancer Center
ViroMissile, Inc.
Arcus Biosciences, Inc.
AstraZeneca
Tizona Therapeutics, Inc
Aulos Bioscience, Inc.
Essen Biotech
Clasp Therapeutics, Inc.
Eli Lilly and Company
Baylor College of Medicine
University of Colorado, Denver
MacroGenics
City of Hope Medical Center
Daiichi Sankyo
Eli Lilly and Company
Boehringer Ingelheim
IDEAYA Biosciences
Second Life Therapeutics
Ocellaris Pharma, Inc.
Medical College of Wisconsin
National Institutes of Health Clinical Center (CC)
Var2 Pharmaceuticals
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Pfizer
University Health Network, Toronto
NeoTX Therapeutics Ltd.
BicycleTx Limited
IDEAYA Biosciences
National Institutes of Health Clinical Center (CC)
Rondo Therapeutics
Actym Therapeutics, Inc.
University of Arizona
Memorial Sloan Kettering Cancer Center
Institut Bergonié
Day One Biopharmaceuticals, Inc.
Shanghai Escugen Biotechnology Co., Ltd
Washington University School of Medicine
Palleon Pharmaceuticals, Inc.
Jonsson Comprehensive Cancer Center
Cancer Research UK
Incyte Corporation
The Netherlands Cancer Institute
Trishula Therapeutics, Inc.
Incyte Corporation